Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-26 4:47 pm Purchase | 2025-08-19 | 13G | iBio, Inc. IBIO | Affinity Healthcare Fund, LP | 4,280,000 9.990% | 4,280,000 (New Position) | Filing History |
| 2025-08-25 5:20 pm Purchase | 2025-08-22 | 13G | iBio, Inc. IBIO | Point72 Asset Management, L.P. | 14,289,118 9.900% | 14,289,118 (New Position) | Filing History |
| 2025-08-14 9:13 pm Purchase | 2025-06-30 | 13G | iBio, Inc. IBIO | ADAR1 Capital Management, LLC | 1,794,055 9.900% | 698,088 (+63.70%) | Filing History |
| 2025-07-30 08:40 am Purchase | 2025-06-30 | 13G | iBio, Inc. IBIO | Patrick J. Crutcher | 847,044 3.100% | 150,331 (+21.58%) | Filing History |
| 2025-02-14 9:10 pm Purchase | 2024-12-31 | 13G | iBio, Inc. IBIO | ADAR1 Capital Management, LLC | 1,095,967 9.990% | 129,669 (+13.42%) | Filing History |
| 2025-02-14 06:42 am Purchase | 2024-12-31 | 13G | iBio, Inc. IBIO | Opaleye Management Inc. | 750,000 7.600% | 100,000 (+15.38%) | Filing History |
| 2025-01-30 6:38 pm Sale | 2025-01-28 | 13G | iBio, Inc. IBIO | Patrick J. Crutcher | 696,713 7.000% | -18,000 (-2.52%) | Filing History |
| 2025-01-29 7:33 pm Purchase | 2025-01-28 | 13G | iBio, Inc. IBIO | Patrick J. Crutcher | 714,713 7.200% | 714,713 (New Position) | Filing History |
| 2025-01-03 5:19 pm Sale | 2024-12-31 | 13G | iBio, Inc. IBIO | SABBY MANAGEMENT LLC | 19,250 0.200% | -181,053 (-90.39%) | Filing History |
| 2024-11-14 8:47 pm Purchase | 2024-09-30 | 13G | iBio, Inc. IBIO | Ikarian Capital, LLC | 599,913 6.600% | 599,913 (New Position) | Filing History |
| 2024-11-14 4:48 pm Purchase | 2024-09-30 | 13G | iBio, Inc. IBIO | ADAR1 Capital Management, LLC | 966,298 9.990% | 966,298 (New Position) | Filing History |
| 2024-04-09 5:22 pm Unchanged | 2024-03-28 | 13G | iBio, Inc. IBIO | Opaleye Management Inc. | 650,000 7.630% | 0 (Unchanged) | Filing History |
| 2024-04-08 8:18 pm Purchase | 2024-03-28 | 13G | iBio, Inc. IBIO | Opaleye Management Inc. | 650,000 7.630% | 650,000 (New Position) | Filing History |
| 2024-04-05 5:11 pm Purchase | 2024-03-26 | 13G | iBio, Inc. IBIO | ADAR1 Partners LP | 789,293 9.270% | 789,293 (New Position) | Filing History |
| 2024-04-01 7:23 pm Purchase | 2024-03-26 | 13G | iBio, Inc. IBIO | Lynx1 Capital Management LP | 878,492 9.990% | 878,492 (New Position) | Filing History |
| 2024-02-13 5:06 pm Purchase | 2023-12-29 | 13G | iBio, Inc. IBIO | VANGUARD GROUP INC | 8,439 0.230% | 8,439 (New Position) | Filing History |
| 2024-01-04 08:00 am Purchase | 2023-12-31 | 13G | iBio, Inc. IBIO | SABBY MANAGEMENT LLC | 200,303 11.000% | 200,303 (New Position) | Filing History |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | iBio, Inc. IBIO | VANGUARD GROUP INC | 23,780 5.280% | 23,780 (New Position) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | iBio, Inc. IBIO | BlackRock Inc. BLK | 7,921 1.800% | -23,032 (-74.41%) | Filing History |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | iBio, Inc. IBIO | BlackRock Inc. BLK | 30,953 7.100% | 7,803 (+33.71%) | Filing History |